Frequency of Metabolic Risk Factors and Association with Demographic Characteristics in Patients with Non-alcoholic Fatty Liver Disease : Metabolic Risk Factors and Demographic Characteristics with NAFLD

Tajwar Gul; Saera Suhail Kidwai; Muhammad Kamran; Hafiz Abdul Basit; Afsheen Ishfaq; Mehrunisa Umar

doi:10.54393/pjhs.v7i6.4047

Authors

Tajwar Gul Department of Internal Medicine, Fazaia Ruth Pfau Medical College and Teaching Hospital, Karachi, Pakistan
Saera Suhail Kidwai Department of Internal Medicine, Fazaia Ruth Pfau Medical College and Teaching Hospital, Karachi, Pakistan
Muhammad Kamran Department of Gastroenterology, Fazaia Ruth Pfau Medical College and Teaching Hospital, Karachi, Pakistan
Hafiz Abdul Basit Department of Gastroenterology, Fazaia Ruth Pfau Medical College and Teaching Hospital, Karachi, Pakistan
Afsheen Ishfaq Department of Internal Medicine, Fazaia Ruth Pfau Medical College and Teaching Hospital, Karachi, Pakistan
Mehrunisa Umar Department of Internal Medicine, Fazaia Ruth Pfau Medical College and Teaching Hospital, Karachi, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v7i6.4047

Keywords:

Non-alcoholic Fatty Liver Disease, Diabetes Mellitus, Hypertension, Hypertriglyceridemia, Hypercholesterolemia, Obesity

Abstract

Non-alcoholic fatty liver disease is a rapidly growing public health concern worldwide and is closely associated with metabolic and cardiovascular risk factors. Objectives: To determine the frequency and demographic associations of metabolic and cardiovascular risk factors among patients with NAFLD. Methods: This analytical cross-sectional study was conducted at the Department of Medicine, Fazaia Ruth Pfau Medical College, Base Faisal, Karachi, from June 2025 to December 2025. A total of 121 patients with NAFLD were enrolled through consecutive sampling. Diagnosis was based on elevated alanine aminotransferase levels and ultrasonographic evidence of fatty liver. Patients with significant alcohol intake, viral hepatitis, or other chronic liver diseases were excluded. Results: The mean age of the patients was 37.18±10.30 years, with a mean BMI of 27.27±4.27 kg/m², and a predominance of males (80.2%). Diabetes mellitus was present in 16.5% of patients, hypertension in 15.7%, and ischemic heart disease in 5.8%. Dyslipidemia was frequently observed, with hypertriglyceridemia in 47.1% and hypercholesterolemia in 27.3%, while obesity was identified in 31.4% of cases. A significant association was observed between age greater than 40 years and the presence of diabetes, hypertension, and ischemic heart disease (p<0.001). Conclusion: NAFLD is strongly associated with metabolic risk factors, particularly dyslipidemia and obesity, with a significant clustering of cardiovascular comorbidities in older individuals.

References

Han SK, Baik SK, Kim MY. Non-Alcoholic Fatty Liver Disease: Definition and Subtypes. Clinical and Molecular Hepatology. 2022 Dec; 29(Suppl): S5. doi: 10.3350/cmh.2022.0424.

Pouwels S, Sakran N, Graham Y, Leal A, Pintar T, Yang W et al. Non-Alcoholic Fatty Liver Disease (NAFLD): A Review of Pathophysiology, Clinical Management and Effects of Weight Loss. BioMed Central Endocrine Disorders. 2022 Mar; 22(1): 63. doi: 10.1186/s12902-022-00980-1.

Elhoseeny MM, Rageh F, Rezk SM, Othman AA. Frequency and Risk Factors of Metabolic-Associated Fatty Liver Disease among Medical Students in Egypt. Scientific Reports. 2025 Apr; 15(1): 13470. doi: 10.1038/s41598-025-95753-w.

Bawiskar N, Acharya S, Kumar S. Fatty Liver Disease-Non-Alcoholic to Metabolic-A Transition of Concepts. Journal of Family Medicine and Primary Care. 2024 Aug; 13(8): 2857-62. doi: 10.4103/jfmpc.jfmpc_1863_21.

Zhou Q, Wang Y, Wang J, Liu Y, Qi D, Yao W et al. Prevalence and Risk Factor Analysis for the Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus. Medicine. 2021 Mar; 100(10): e24940. doi: 10.1097/MD.0000000000024940.

Grander C, Grabherr F, Tilg H. Non-Alcoholic Fatty Liver Disease: Pathophysiological Concepts and Treatment Options. Cardiovascular Research. 2023 Jul; 119(9): 1787-98. doi: 10.1093/cvr/cvad095.

Niu Y, Wang G, Feng X, Niu H, Shi W. Significance of Fatty Liver Index to Detect Prevalent Ischemic Heart Disease: Evidence from National Health and Nutrition Examination Survey 1999–2016. Frontiers in Cardiovascular Medicine. 2023 Oct; 10: 1171754. doi: 10.3389/fcvm.2023.1171754.

Lajeunesse-Trempe F, Dugas S, Maltais-Payette I, Tremblay ÈJ, Piché ME, Dimitriadis GK et al. Anthropometric Indices and Metabolic Dysfunction–Associated Fatty Liver Disease in Males and Females Living with Severe Obesity. Canadian Journal of Gastroenterology and Hepatology. 2025; 2025(1): 5545227. doi: 10.1155/cjgh/5545227.

Martin A, Lang S, Goeser T, Demir M, Steffen HM, Kasper P. Management of Dyslipidemia in Patients with Non-Alcoholic Fatty Liver Disease. Current Atherosclerosis Reports. 2022 Jul; 24(7): 533-46. doi: 10.1007/s11883-022-01028-4.

Hu R, Wu B, Wang C, Wu Z, Zhang X, Chen X et al. Assessment of Transient Elastography in Diagnosing MAFLD and the Early Effects of Sleeve Gastrectomy on MAFLD among the Chinese Population. International Journal of Surgery. 2024 Apr; 110(4): 2044-54. doi: 10.1097/JS9.0000000000001078.

Robea MA, Balmus IM, Girleanu I, Huiban L, Muzica C, Ciobica A et al. Coagulation Dysfunctions in Non-Alcoholic Fatty Liver Disease—Oxidative Stress and Inflammation Relevance. Medicina. 2023 Sep; 59(9): 1614. doi: 10.3390/medicina59091614.

Lupsor-Platon M, Serban T, Silion AI, Tirpe GR, Tirpe A, Florea M. Performance of Ultrasound Techniques and the Potential of Artificial Intelligence in the Evaluation of Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease. Cancers. 2021 Feb; 13(4): 790. doi: 10.3390/cancers13040790.

Tunio YM, Farhad R, Rashid A, Ansari NU, Chaudhary S, Iqbal W et al. Incidence of Non-Alcoholic Fatty Liver Disease and Associated Risk Factors. Pakistan Journal of Medical Health Sciences. 2021; 15(11): 3247-51. doi: 10.53350/pjmhs2115113247.

Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The Global Epidemiology of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH): A Systematic Review. Hepatology. 2023 Apr; 77(4): 1335-47. doi: 10.1097/HEP.0000000000000004.

Kannan S, Nelliyanil M, Mendagudli R, Rajeshwari S, Kona C, Kundapur R et al. Evaluation of Risk Factors for Non-Alcoholic Fatty Liver Disease in India: A Systematic Review and Meta-Analysis. Journal of Education and Health Promotion. 2023 Dec; 12(1): 435. doi: 10.4103/jehp.jehp_208_23.

Amini-Salehi E, Hassanipour S, Joukar F, Daryagasht AA, Khosousi MJ, Aleali MS et al. Risk Factors of Non-Alcoholic Fatty Liver Disease in the Iranian Adult Population: A Systematic Review and Meta-Analysis. Hepatitis Monthly. 2023 Dec; 23(1): 1. doi: 10.5812/hepatmon-131523.

Wang G, Shen X, Wang Y, Lu H, He H, Wang X. Analysis of Risk Factors Related to Nonalcoholic Fatty Liver Disease: A Retrospective Study Based on 31,718 Adult Chinese Individuals. Frontiers in Medicine. 2023 Jun; 10: 1168499. doi: 10.3389/fmed.2023.1168499.

Huh Y, Cho YJ, Nam GE. Recent Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease. Journal of Obesity and Metabolic Syndrome. 2022 Mar; 31(1): 17. doi: 10.7570/jomes22021.

Bano U, Gondal M, Moin S. Evaluation of Risk Factors of Non-Alcoholic Fatty Liver Disease (NAFLD) in A Tertiary Care Hospital at Rawalpindi, Pakistan: A Local Experience. Journal of Postgraduate Medical Institute. 2008; 22(3).

Mahmood HA, Abbas MA, Azeem MA, Younus IR, Qadir AD, Habib MU. The Risk Factors Associated with Non-Alcoholic Fatty Liver Disease. Pakistan Journal of Medical Health Sciences. 2023; 17(4): 458-61. doi: 10.53350/pjmhs2023174458.

Losasso MR, Parussolo ML, Oliveira Silva A, Direito R, Quesada K, Penteado Detregiachi CR et al. Unraveling the Metabolic Pathways Between Metabolic-Associated Fatty Liver Disease (MAFLD) and Sarcopenia. International Journal of Molecular Sciences. 2025 May; 26(10): 4673. doi: 10.3390/ijms26104673.

Akter S. Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Risk Factors and Pathophysiology. Middle East Journal of Digestive Diseases. 2022 Apr; 14(2): 167. doi: 10.34172/mejdd.2022.270.